Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
2020
Online
Elektronische Ressource
Two methods combining survival and health-related quality of life (HRQoL) data in glioma trials to calculate the "net clinical benefit" were evaluated: Quality-adjusted effect sizes (QASES) and joint modeling (JM).
Funding agencies: The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group [grant application number: CODAGLIO v1 005 2015].
Titel: |
Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling
|
---|---|
Link: | |
Veröffentlichung: | 2020 |
Medientyp: | Elektronische Ressource |
DOI: | 10.1093.noajnl.vdaa147 |
Schlagwort: |
|
Sonstiges: |
|